Glioblastoma exhibits sex-specific differences in disease progression, incidence and immune regulation. Now, Pathak et al. identify GABA (γ-aminobutyric acid) as a key driver of granulocytic myeloid-derived suppressor cell-mediated glioblastoma progression in women.
原文链接
分享
引用
